Federal Register of Legislation - Australian Government

Primary content

Food Standards as made
This instrument varies standards in the revised Australia New Zealand Food Standards Code.
Administered by: Health
Exempt from sunsetting by the Food Standards Australia New Zealand Act 1991 s 94, Legislative Instruments Act 2003 s 54(1)
Registered 12 Jan 2016
Tabling HistoryDate
Tabled HR02-Feb-2016
Tabled Senate02-Feb-2016
Date of repeal 02 Mar 2016
Repealed by Division 1 of Part 5A of the Legislative Instruments Act 2003

Description: FS_Logo_K

 

Food Standards (Application A1108 – Rebaudioside M as a Steviol Glycoside Intense Sweetener) Variation

 

 

The Board of Food Standards Australia New Zealand gives notice of the making of this variation under section 92 of the Food Standards Australia New Zealand Act 1991. The Standard commences on the date specified in clause 3 of this variation.

 

Dated 8 January 2016

Standards Management Officer

Delegate of the Board of Food Standards Australia New Zealand

 

 

 

 

 

Note: 

 

This variation will be published in the Commonwealth of Australia Gazette No. FSC 102 on 14 January 2016.

 

1             Name of instrument

This instrument is the Food Standards (Application A1108 – Rebaudioside M as a Steviol Glycoside Intense Sweetener) Variation.

2             Variation to Standards in the Australia New Zealand Food Standards Code

The Schedule varies Standards in the Australia New Zealand Food Standards Code.

3             Commencement

The variation commences on 1 March 2016 immediately after the commencement of Standard 5.1.1 – Revocation and transitional provisions – 2014 Revision.

Schedule

[1]           Standard 1.3.1 is varied by omitting paragraphs (g) to (j) of the definition of CF in subsection 1.3.1—4(7), and substituting

“                           (g)      rebaudioside M—0.25;

                            (h)      rubusoside—0.50;

                            (i)       steviolbioside—0.50;

                            (j)       stevioside—0.40.”

[2]           Schedule 3 is varied by

[2.1]        inserting in the table to subsection S3—2(2) in alphabetical order

rebaudioside M

section S3—31

steviol glycoside mixtures including rebaudioside M

section S3—32

[2.2]        inserting after section S3—30

S3—31               Specification for rebaudioside M

                   (1)      In this section:

rebaudioside M means the chemical with the Chemical Abstracts Service Registry Number 1220616-44-3 and the formula C56H90O33.

                   (2)      For rebaudioside M, the specifications are the following:

                            (a)      assay—comprise not less than 95% on the dried basis;

                            (b)      Chemical nameRebaudioside M: 13-[(2-O-β-D-glucopyranosyl-3-O-β-D-glucopyranosyl-β-D-glucopyranosyl)oxy]kaur-16-en-18-oic acid, 2-O-β-D-glucopyranosyl-3-O-β-D-glucopyranosyl-β-D-glucopyranosyl ester;

                            (c)      Formula weight1,291.3.

                   (3)      Subject to subsection (2), rebaudioside M must comply with one of the specifications that relate to steviol glycosides and that is listed in a primary source named in paragraph S32(1)(b), S32(1)(c) or S32(1)(d).

S3—32                Specification for steviol glycoside mixture including rebaudioside M

                   (1)      In this section:

prescribed steviol glycosides are:

                            (a)      dulcoside A;

                            (b)      rebaudioside A;

                            (c)      rebaudioside B;

                            (d)      rebaudioside C;

                            (e)      rebaudioside D;

                            (f)      rebaudioside F;

                            (g)      rubusoside;

                            (h)      steviolbioside; and

                            (i)       stevioside.

                   (2)      This specification relates to a mixture that contains rebaudioside M and one or more prescribed steviol glycosides.

                   (3)      The rebaudioside M and the prescribed steviol glycoside or glycosides must together comprise not less than 95% of the mixture on the dried basis.

                   (4)      Subject to subsection (3), the mixture must also comply with one of the specifications that relate to prescribed steviol glycosides and that is listed in a primary source named in paragraph S32(1)(b), S32(1)(c) or S32(1)(d).